Sci Pharmtech (TPE:4119) Days Inventory: 252.64 (As of Dec. 2025) — 34% Above Median


TPE:4119 Sci Pharmtech Inc TPE:4119
67 GF Score
Price NT$44.75
GF Value NT$96.77
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Sci Pharmtech Days Inventory?

Sci Pharmtech TPE:4119 67 Days Inventory is 252.64 as of Dec. 2025, which is 34% above its 10-year median of 188.20. GuruFocus rates TPE:4119 with a GF Score™ of 67/100 and a GF Value™ of NT$96.77 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 919 Drug Manufacturers companies, Sci Pharmtech ranks worse than 73.56% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). Sci Pharmtech's Average Total Inventories for the three months ended in Dec. 2025 was NT$708 Mil. Sci Pharmtech's Cost of Goods Sold for the three months ended in Dec. 2025 was NT$256 Mil. Hence, Sci Pharmtech's Days Inventory for the three months ended in Dec. 2025 was 252.64.

The historical rank and industry rank for Sci Pharmtech's Days Inventory or its related term are showing as below:

TPE:4119' s Days Inventory Range Over the Past 10 Years
Min: 117.11   Med: 188.2   Max: 248.04
Current: 238.97

During the past 13 years, Sci Pharmtech's highest Days Inventory was 248.04. The lowest was 117.11. And the median was 188.20.

TPE:4119's Days Inventory is ranked worse than
73.56% of 919 companies
in the Drug Manufacturers industry
Industry Median: 164.48 vs TPE:4119: 238.97

Sci Pharmtech's Days Inventory increased from Dec. 2024 (183.71) to Dec. 2025 (252.64). It might indicate that Sci Pharmtech's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Sci Pharmtech's Inventory Turnover for the three months ended in Dec. 2025 was 0.36.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sci Pharmtech's Inventory-to-Revenue for the three months ended in Dec. 2025 was 1.99.


Sci Pharmtech  (TPE:4119) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sci Pharmtech's Inventory Turnover for the three months ended in Dec. 2025 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sci Pharmtech's Inventory to Revenue for the three months ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Sci Pharmtech Days Inventory Related Terms


Sci Pharmtech Days Inventory Historical Data

* Premium members only.

The historical data trend for Sci Pharmtech's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sci Pharmtech Days Inventory Chart

Sci Pharmtech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 187.77 242.19 222.92 188.63 248.04

Sci Pharmtech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 183.71 198.23 206.62 315.37 252.64

TPE:4119 vs ZTS, UTHR: Days Inventory Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sci Pharmtech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sci Pharmtech Days Inventory vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sci Pharmtech's Days Inventory distribution charts can be found below:

* The bar in red indicates where Sci Pharmtech's Days Inventory falls into.


TPE:4119
67GF Score
Sci Pharmtech Inc TPE:4119
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sci Pharmtech Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sci Pharmtech's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (620.897 + 728.301) / 2 ) / 992.695*365
=674.599 / 992.695*365
=248.04

Sci Pharmtech's Days Inventory for the quarter that ended in Dec. 2025 is calculated as:

Days Inventory (Q: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Sep. 2025 ) + Total Inventories (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (688.551 + 728.301) / 2 ) / 255.875*365 / 4
=708.426 / 255.875*365 / 4
=252.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 252.64 mean?
Sci Pharmtech (TPE:4119) has a Days Inventory of 252.64 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sci Pharmtech and its competitors. This is 34% above median its historical median of 188.20. Over the past decade, Sci Pharmtech's Days Inventory has ranged from 117.11 to 248.04. According to the industry distribution chart, Sci Pharmtech ranks #676 out of 919 companies in the Drug Manufacturers industry, placing it in the top 73.6%.
Is Sci Pharmtech's Days Inventory too high?
Sci Pharmtech's current Days Inventory of 252.64 is 34% above median its 10-year median of 188.20. Over the past 10 years, this metric has ranged from a low of 117.11 to a high of 248.04. The Drug Manufacturers industry median Days Inventory is 164.48. Sci Pharmtech's value of 252.64 is 53.6% above this industry median. Based on the distribution chart, Sci Pharmtech ranks #676 out of 919 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sci Pharmtech has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sci Pharmtech's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sci Pharmtech ranks #676 out of 919 companies for Days Inventory. This places Sci Pharmtech in the lower half of its industry. The industry median Days Inventory is 164.48. Sci Pharmtech's value of 252.64 is 53.6% above this benchmark. Historically, Sci Pharmtech's own Days Inventory has ranged from 117.11 to 248.04 over the past decade. While the company's 10-year median is 188.20 vs. the industry median of 164.48, Sci Pharmtech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sci Pharmtech's current Days Inventory of 252.64 is 53.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sci Pharmtech and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sci Pharmtech's current Days Inventory is 252.64, which is 34% above median its own 10-year median of 188.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sci Pharmtech stock overvalued right now?
Based on GuruFocus' analysis, Sci Pharmtech (TPE:4119) is currently considered Possible Value Trap. The stock's GF Value™ is NT$96.77, compared to a current price of NT$44.75 — trading 53.8% below its estimated fair value. The current Days Inventory is 252.64, which is 34% above median its 10-year median of 188.20 and 53.6% above the Drug Manufacturers industry median of 164.48. Sci Pharmtech's overall GF Score™ is 67/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sci Pharmtech (TPE:4119), the current Days Inventory is 252.64 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sci Pharmtech (TPE:4119) Overvalued in 2026?

Based on GuruFocus' analysis, Sci Pharmtech stock appears to be undervalued. The current stock price of NT$44.75 is trading 53.8% below its estimated GF Value™ of NT$96.77. GuruFocus considers Sci Pharmtech to be Possible Value Trap.

Key valuation signals for TPE:4119:

  • Days Inventory: 252.64 (34% above median its 10-year median of 188.20)
  • GF Value™: NT$96.77 vs. price of NT$44.75 (53.8% below fair value)
  • GF Score™: 67/100 with 9 warning signs
  • Industry Position: 53.6% above the Drug Manufacturers median (#676 of 919)

No single metric tells the full story. See the TPE:4119 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sci Pharmtech Business Description

Address No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856
Sci Pharmtech Inc is engaged in the research and development, manufacture, and sales of active pharmaceutical ingredients, intermediates, and specialty chemicals. Geographically, the primary markets of the company are Italy, Germany, Japan, Taiwan, the United States, Switzerland, Spain, Belgium, Netherlands, and others.
67GF Score

Get the complete analysis for TPE:4119

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$44.75
Price
NT$96.77
GF Value